Internal Medicine
Critical illness–induced corticosteroid insufficiency: what it is not and what it could be.
24 May, 2022 | 08:01h | UTC
M-A: Systemic pharmacological treatments for chronic plaque psoriasis.
24 May, 2022 | 08:00h | UTC
Podcast: Updates in addiction medicine.
24 May, 2022 | 07:58h | UTC#336 Updates in Addiction Medicine: Live From SGIM – The Curbsiders
Expert Analysis: Vascular toxicities of novel cancer therapies.
24 May, 2022 | 07:50h | UTCVascular Toxicities of Novel Cancer Therapies – American College of Cardiology
Review: Current and emerging classes of pharmacological agents for the management of hypertension.
24 May, 2022 | 07:47h | UTCCurrent and Emerging Classes of Pharmacological Agents for the Management of Hypertension – American Journal of Cardiovascular Drugs (if the link is paywalled, try this one)
Cohort Study: Pneumococcal urinary antigen testing for antimicrobial guidance in community-acquired pneumonia.
24 May, 2022 | 07:36h | UTC
Commentary on Twitter
🆕💥Large register-based cohort study
To evaluate the effect of pneumococcal urinary antigen test usage on broad-spectrum antibiotic treatment in CAP
Performing urinary antigen test has little effect on antibiotic therapy in pneumonia #IDTwitterhttps://t.co/Cxg9FDEUqk— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) May 23, 2022
Under a CC BY 4.0 license
M-A: Effect of Sodium-Glucose Cotransporter 2 Inhibitors for heart failure with preserved ejection fraction.
24 May, 2022 | 07:33h | UTC
Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update.
23 May, 2022 | 01:58h | UTC
Commentary on Twitter
Just published 💥💥 @ICHEJournal @SHEA_Epi @IDSAInfo @APIC
Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update #IDTwitter https://t.co/fipGfkyHi6 pic.twitter.com/c88X5GL0d6— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) May 20, 2022
Under a http://creativecommons.org/licenses/by/4.0/ license
NICE rapid guideline update on the management of Covid-19.
23 May, 2022 | 01:56h | UTCCOVID-19 rapid guideline: managing COVID-19 – National Institute for Health and Care Excellence
RCT: High-flow nasal oxygen is not beneficial for patients with COVID-19 pneumonia and mild hypoxemia.
23 May, 2022 | 01:51h | UTC
WHO: Multi-country monkeypox outbreak in non-endemic countries.
23 May, 2022 | 01:46h | UTCMulti-country monkeypox outbreak in non-endemic countries – World Health Organization
Monkeypox goes global: why scientists are on alert – Nature
Monkeypox: What do we know about the outbreaks in Europe and North America? – The BMJ
Seven Confirmed Monkeypox Cases in UK Includes Sexually Transmitted Cluster – STAT
Monkeypox: Time to worry or one to ignore? – BBC
UK, Spain, Portugal report more monkeypox cases – CIDRAP
U.S. monkeypox case reported, as Spain, Portugal report infections in growing outbreak – STAT
Monkeypox – United Kingdom of Great Britain and Northern Ireland – World Health Organization
Monkeypox cases confirmed in England – latest updates – UK Health Security Agency
Seven Confirmed Monkeypox Cases in UK Includes Sexually Transmitted Cluster – Health Policy Watch
European outbreak of monkeypox: what you need to know – The Conversation
Rare monkeypox outbreak in U.K., Europe and U.S.: What is it and should we worry – NPR
Monkeypox cases under investigation in Canada as outbreak spreads in Europe, U.S. – CBC News
Commentary on Twitter
The WHO has started to report data on the monkeypox outbreak: https://t.co/e3Q23sllvX pic.twitter.com/3WKqj79eLy
— Max Roser (@MaxCRoser) May 22, 2022
Review: Hypothyroidism.
23 May, 2022 | 01:49h | UTCHypothyroidism – Nature Reviews Disease Primers (if the link is paywalled, try this one)
Infographic: Hypothyroidism – Nature Reviews Disease Primers (if the link is paywalled, try this one)
Systematic Review: Prophylactic antiemetics for adults receiving intravenous opioids in the acute care setting.
23 May, 2022 | 01:29h | UTC
Drugs for agitation in people with dementia: benefits and risks.
23 May, 2022 | 01:25h | UTCDrugs for agitation in people with dementia: benefits and risks – Evidently Cochrane
Original Study: Antipsychotics for agitation and psychosis in people with Alzheimer’s disease and vascular dementia – Cochrane Library
Commentary on Twitter (thread – click for more)
https://twitter.com/CochraneUK/status/1527579340350935045
Preventing dementia: what’s the evidence?
23 May, 2022 | 01:27h | UTCPreventing dementia: what’s the evidence? – Evidently Cochrane
Cohort Study: Association of thyroid hormone treatment intensity with cardiovascular mortality.
23 May, 2022 | 01:23h | UTCCommentaries:
Thyroid Hormone Treatment Intensity and Cardiovascular Mortality – American College of Cardiology
Thyroid Hormone Treatment Intensity May Be Modifiable Risk Factor for CV Mortality – HCP Live
Commentary on Twitter
In this cohort study of US Veterans on thyroid hormone therapy, both exogenous hyperthyroidism and hypothyroidism contributed to the increased risk of cardiovascular mortality after adjusting for demographic and traditional cardiovascular risk factors. https://t.co/NO4776Ia4m
— JAMA Network Open (@JAMANetworkOpen) May 12, 2022
Review: Allergic asthma is a risk factor for human cardiovascular diseases.
23 May, 2022 | 00:48h | UTCAllergic asthma is a risk factor for human cardiovascular diseases – Nature Cardiovascular Research
Commentary on Twitter
A Review in @NatureCVR discusses how asthma and allied allergic conditions may contribute to the prevalence, incidence and progression of cardiovascular diseases and vice versa. https://t.co/6kRj9LvOfa pic.twitter.com/Ydq8X2k1rY
— Nature Portfolio (@NaturePortfolio) May 18, 2022
Low-flow acute kidney injury: the pathophysiology of prerenal azotemia, abdominal compartment syndrome, and obstructive uropathy.
23 May, 2022 | 00:43h | UTC
AHA Scientific Statement: Preventing and managing falls in adults with cardiovascular disease.
20 May, 2022 | 11:20h | UTCNews Release: Statement addresses ways to prevent heart-related risks for falling – American Heart Association
Commentary: AHA News: Falls Can Be a Serious, Poorly Understood Threat to People With Heart Disease – HealthDay
Covid-19: Second boosters may benefit at-risk groups but have “minimal” impact for others, says WHO.
20 May, 2022 | 11:08h | UTCOriginal Statement: Interim statement on the use of additional booster doses of Emergency Use Listed mRNA vaccines against COVID-19 – World Health Organization
Related recommendations:
COVID-19 evidence: a Cochrane round-up.
20 May, 2022 | 11:14h | UTCCOVID-19 evidence: a Cochrane round-up – Cochrane Library
Systematic Review: Thoracic imaging tests for the diagnosis of COVID‐19.
20 May, 2022 | 11:13h | UTCThoracic imaging tests for the diagnosis of COVID‐19 – Cochrane Library
Summary: How accurate is chest imaging for diagnosing COVID-19? – Cochrane Library
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality.
20 May, 2022 | 11:06h | UTC
Commentary on Twitter
CMV reactivation in #COVID19 critically ill pts:
🦠frequent! >20% in this study
🧪risk depends on severity of illness/occurrence of secondary bacterial infections in #ICU
🏥 prolonged hospital stay & higher mortality but independent association lacking.
📎 https://t.co/N8JVD1GyPQ pic.twitter.com/KYRtLmxtJg— Intensive Care Medicine (@yourICM) May 18, 2022
SCAI guidelines for the management of patent foramen Ovale.
20 May, 2022 | 11:01h | UTCSCAI Guidelines for the Management of Patent Foramen Ovale – JSCAI
Editorial: New SCAI Guidelines: Trying to Close the Holes in the PFO Literature – JSCAI
Commentary: PFO Closure Guidelines Address Older Adults, Trial-Excluded Groups— Document acknowledges skimpy evidence – MedPage Today (free registration required)
Related:
Advances in the management of cardioembolic stroke associated with patent foramen ovale – The BMJ
Heterogeneity of Treatment Effects in an Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale After Stroke – JAMA (link to abstract – $ for full-text)
RCT: Apixaban is not superior to the standard of care (vitamin K antagonist or antiplatelet therapy if anticoagulation is indicated or not, respectively) after transcatheter aortic valve implantation.
20 May, 2022 | 10:59h | UTCApixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial – European Heart Journal (link to abstract – $ for full-text)
Related: